Neuroscience

Greater benefit for pioglitazone in high-risk patients post stroke

(HealthDay)—For patients after an ischemic stroke or transient ischemic attack, pioglitazone is associated with greater benefit for those at higher risk for stroke or myocardial infarction (MI), according to a study published ...

Neuroscience

Warfarin, rivaroxaban similarly safe, effective

(HealthDay)—For cases of mild atrial fibrillation (AF)-related acute ischemic stroke, rivaroxaban and warfarin are similarly safe and effective at preventing recurrent stroke, according to a study published online Sept. ...

Neuroscience

Speech therapy after a stroke

Dear Mayo Clinic: My mother had a stroke six months ago. Her mobility has returned to near normal. She can read and understands others when they speak. But she has a lot of difficulty talking, often struggling to find the ...

Cardiology

Higher BMI in childhood linked to adult stroke risk

(HealthDay)—Above-average childhood body mass index (BMI) and increases in BMI during childhood are associated with increased risk of early adult ischemic stroke, according to a study published online Aug. 21 in JAMA Neurology.

Cardiology

New cancer diagnosis may come with risk of thromboembolism

Patients newly diagnosed with cancer may have a substantially increased short-term risk of arterial thromboembolism, according to a study published today in the Journal of the American College of Cardiology.

Cardiology

Men, not women, may be having fewer strokes

The overall rate of stroke in the United States has been declining in recent years and while that has been good news, a new study suggests it may be primarily good news for men. The research, published in the August 9, 2017, ...

Cardiology

Quitting statins after stroke may raise risk of another stroke

Stroke patients who stopped taking statin drugs three to six months after a first ischemic stroke, the type caused by narrowed arteries, had a higher risk of a having another stroke within a year, according to new research ...

Cardiology

Rivaroxaban OK for stroke prevention in cancer patients

(HealthDay)—The safety and efficacy of rivaroxaban treatment for nonvalvular atrial fibrillation (AF) in patients with active cancer is similar to the general population, according to a study published in the July 15 issue ...

page 39 from 40